Its therapeutic forms have been implicated in athletic doping as well
protein-focused meals Solution: Lower dose or extend interval Less Common Headache (usually caffeine withdrawal symptom) Fatigue (often electrolyte-related) Mild dizziness on initial doses Changes in taste preferences Serious (Rare) Pancreatitis symptoms (severe abdominal pain, vomiting) Thyroid changes (monitor TSH) Gallbladder issues (existing risk patients) Allergic reactions Monitor closely for serious symptoms
GLP-1 receptor agonists used in obesity care aim to reduce hunger and improve satiety signalling for many patients, alongside diet and physical activity, when a UK-registered prescriber selects them
Huang HY, Helzlsouer KJ, Appel LJ
Genetic predispositions affecting GLP-1 pathway sensitivity include variants in GIPR, and FTO genes, which may influence receptor density, glucose homeostasis responsiveness, and weight regulation set-point